<DOC>
	<DOC>NCT00372294</DOC>
	<brief_summary>Toxoplasmosis, an intra cellular parasite, is a very important cause of chorioretinitis. The goal of treatment is arresting multiplication of the parasite in its inflammatory active phase. In this study the investigators try to compare the efficacy of the classic regimen (Pyrimethamine-Sulfadiazine + Prednisolon) with intravitreal Clindamycin &amp; Dexamethasone.</brief_summary>
	<brief_title>To Compare Intravitreal Clindamycin &amp; Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis</brief_title>
	<detailed_description />
	<mesh_term>Chorioretinitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Sulfadiazine</mesh_term>
	<criteria>Patients with Toxoplasmic chorioretinitis Location of the lesion within zone I of the retina or a lesion greater than 2DD with 3+4+ vitreous inflammation in zone II or III No allergic history to the used drugs No any other diseases Any allergic reaction to the used medications One eyed patients Partially treated patients</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Toxoplasmosis</keyword>
	<keyword>Chorioretinitis</keyword>
	<keyword>Intravitreal Clindamycin</keyword>
	<keyword>Dexamethasone in chorioretinitis</keyword>
	<keyword>Toxoplasmic</keyword>
</DOC>